Monocyte and lymphocyte apoptosis resistance in acute and chronic brucellosis and its possible implications in clinical management

Clinical Infectious Diseases

Volumn 36, Issue 12, 2003, Pages 1533-1538

  Tolomeo, Manlio ^a,b   Di Carlo, P ^a   Abbadessa, V ^a   Titone, L ^a   Miceli, S ^a   Barbusca, E ^a   Cannizzo, G ^a   Mancuso, S ^a   Arista, S ^a   Scarlata, F ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; FAS ANTIBODY; FAS ANTIGEN; RIFAMPICIN; MONOCLONAL ANTIBODY;

ADULT; APOPTOSIS; ARTICLE; BRUCELLA; BRUCELLOSIS; CELL SURFACE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFECTION RESISTANCE; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ACUTE DISEASE; ADOLESCENT; CD8+ T LYMPHOCYTE; CHRONIC DISEASE; IMMUNOLOGY; METABOLISM; PATHOLOGY; PRESCHOOL CHILD;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; BRUCELLA; BRUCELLOSIS; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; HUMANS; LYMPHOCYTES; MONOCYTES;

EID: 0037871933     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/375223     Document Type: Article

References (30)

1. Williams E. Brucellosis. Br Med J 1973; 1:791-3.
2. Darwish M, Benkirane A. Field investigations of brucellosis in cattle and small ruminants in Syria, 1990-1996. Rev Sci Tech 2001; 20:769-75.
3. Dajani YF, Masoud AA, Barakat HF. Epidemiology and diagnosis of human brucellosis in Jordan. J Trop Med Hyg 1989; 92:209-14.
4. Slater PE, Costin C, Seidenbaum M, Ever-Hadani S. Epidemiology of human brucellosis in Israel. Public Health Rev 1990; 18:159-69.
5. Picciotto D, Verso MG, Lacca G, et al. The epidemiological trend of brucellosis in the provinces of Sicily. Med Lav 1999; 90:786-90.
6. Ariza J, Bosch J, Gudiol F, et al. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis. Antimicrob Agents Chemother 1986; 30:958-60.
7. Baldwin CL, Winter AJ. Macrophages and Brucella. Immunol Ser 1994; 60:363-80.
8. Young EJ. Human brucellosis. Rev Infect Dis 1983; 5:821-42.
9. Medzhitov R, Janeway CA. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997; 9:4-9.
10. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc Natl Acad Sci USA 1999; 96:14459-63.
11. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994; 76:287-99.
12. Golding B, Scott DE, Scharf O, et al. Immunity and protection against Brucella abortus. Microbes Infect 2001; 3:43-8.
13. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26:239-57.
14. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407:770-6.
15. Krammer PH, Dhein Y, Valczak H, et al. The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 1994; 142:175-91.
16. Krammer PH. CD95's deadly mission in the immune system. Nature 2000; 407:789-95.
17. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA fo human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66:233-43.
18. Nagata S, Golstein P. The Fas death factor. Science 1955; 267:1449-55.
19. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281:1305-8.
20. Reed JC. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opin Oncol 1995; 7:541-6.
21. Roup JR, Williams-Warren J, Weber A. Pharmacokinetics of rifampin in children: multiple dose intravenous infusion. Ther Drug Monit 1986; 8:17-22.
22. Gross A, Terraza A, Ouahrani-Bettache S, Liautard JP, Dornand J. In vitro Brucella suis infection prevents the programmed cell death of human monocytic cells. Infect Immun 2000; 68:342-51.
23. Durrbaum-Landmann I, Gercken J, Flad HD, Ernst M. Effect of in vitro infection of human monocytes with low numbers of Mycobacterium tuberculosis bacteria on monocyte apoptosis. Infect Immun 1996; 64:5384-9.
24. Kremer L, Estaquier J, Brandt E, Ameisen JC, Locht C. Mycobacterium bovis bacillus Calmette-Guérin infection prevents apoptosis of resting human monocytes. Eur J Immunol 1997; 27:2450-6.
25. Fan T, Lu H, Hu H, et al. Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med 1998; 187:487-96.
26. Clifton DR, Goss RA, Sahni SK, et al. NF-kappa B-dependent inhibition of apoptosis is essential for host cellsurvival during Rickettsia rickettsii infection. Proc Natl Acad Sci USA 1998; 95:4646-51.
27. Giambartolomei GH, Delpino MV, Cahanovich ME, et al. Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis. J Infect Dis 2002; 186:252-9.
28. Landau Z, Green L. Chronic brucellosis in workers in a meat-packing plant. Scand J Infect Dis 1999; 31:511-2.
29. Hong PC, Tsolis RM, Ficht TA. Identification of genes required for chronic persistence of Brucella abortus in mice. Infect Immun 2000; 68:4102-7.
30. Tolomeo M, Grimaudo S, Milano S, et al. Effects of chemically modified tetracyclines (CMTs) in sensitive, multidrug resistant and apoptosis resistant leukaemia cell lines. Br J Pharmacol 2001; 133:306-14.